Abstract:PROTACs (Proteolysis Targeting Chimeras), heterobifunctional molecules, exhibit selectivity in degrading target proteins through E3 ubiquitin ligases. Designing effective PROTACs requires a deep understanding of the intricate binding interactions in the ternary complex (POI/PROTAC/E3 ligase), crucial for efficient target protein degradation. To address this challenge, we introduce a novel computational virtual screening method that considers essential amino acid interactions between the protein of interest and the chosen E3 ligase. This approach enhances accuracy and reliability, facilitating the strategic development of potent PROTACs. Utilizing a crystallized model of the VHL:PROTAC:SMARCA2BD ternary complex (PDB: 7Z6L), we assessed the effectiveness of our method. Our study reveals that increasing the number of essential restraints between the two proteins reduces the generated docking poses, leading to closer alignment with the experimental ternary complex. Specifically, utilizing three restraints showed the closest resemblance to the published complex, highlighting crucial interactions such as an H-bond between A:Gln 89 and B:Asn 67, along with two hydrophobic interactions: A:Gly 22 with B:Arg 69 and A:Glu 37 with B:Pro 99. This resulted in a significant decrease in the mean RMSD value from 31.8 and 31.0 Å to 24.4 Å, respectively. This underscores the importance of incorporating multiple essential restraints to enhance docking accuracy. Building on this progress, we introduce a systematic approach to design potential PROTACs between the Estrogen receptor and the E3 ligase, utilizing bridging intermediates with 4, 6, or 7 carbon atoms. By providing a more accurate and efficient means of identifying optimal PROTAC candidates, this approach has the potential to accelerate the development of targeted therapies and reduce the time and costs associated with drug discovery.Communicated by Ramaswamy H. Sarma.

Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera

Leveraging dual-ligase recruitment to enhance degradation via a heterotrivalent PROTAC

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Dual-ligand PROTACS mediate superior target protein degradation in vitro and therapeutic efficacy in vivo

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras

Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity

In Vivo Target Protein Degradation Induced by PROTACs Based on E3 Ligase DCAF15

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

Bivalent Ligands for Protein Degradation in Drug Discovery

Targeted protein degradation: expanding the toolbox

A modular PROTAC design for target destruction using a degradation signal based on a single amino acid

The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation

Bifunctional Peptide Nanofibrils for Targeted Protein Degradation.

Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity

Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Discovery of E3 Ligase Ligands for Target Protein Degradation

Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation

A close-up shot of protein-protein docking, from experiment to theory and reverse with the PROTAC performers